Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pre-existing cardiovascular disease is associated with an increased risk of cardiovascular events during Bruton tyrosine kinase inhibitor therapy.
Journal: The oncologist
Published: March 07, 2024
Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: February 09, 2023
Targeting CD19 for diffuse large B cell lymphoma in the era of CARs: Other modes of transportation.
Journal: Blood reviews
Published: June 29, 2022
Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemia.
Journal: Expert review of anticancer therapy
Published: April 11, 2022
SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström Macroglobulinemia.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 16, 2022
Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma.
Journal: Blood advances
Published: January 24, 2020
Emerging epigenetic-modulating therapies in lymphoma.
Journal: Nature reviews. Clinical oncology
Published: March 07, 2019
Last Updated: 09/26/2026